A. The Program shall review prescription monitoring data for indications of possible:
(1) Misuse or abuse of a monitored prescription drug; and
(2) Violations of law or possible breaches of professional standards by a prescriber or a dispenser.
B. In determining whether its review indicates a possible violation of law or possible breach of professional standards by a prescriber or dispenser, the Program shall take into account to the extent practicable the particular specialty, circumstances, patient type, and location of the prescriber or dispenser.